Sale on Manual & Electric Hospital Beds - Starting from 25 September!

✓ Certified Professional Seller

Texua Physiotherapy & Wellness Equipment

Texua T501

Product Code: PAWE-EAPD-3211

Half a bar to ten, one to twenty-one hertz, up to 9,900 shots.

Pressure from 0.5 to 10 bar in half-bar steps, frequency from 1 to 21 Hz, and a shot count from 100 to 9,900. An 8-inch touchscreen on a 15.5-kilogram bench unit running at 380 watts

Sections

Shockwave Therapy

Categories

Physiotherapy & Wellness Equipment

Condition

New

Origin

China

Seller Type

Certified Professional Seller

CE & ISO Certified

Global Shipping

Supplier: Medigear

Built by Guangzhou Texua Electronic Technology, the T501 is a radial pressure wave therapy device for physiotherapy, podiatry, and sports injury treatment. Output runs from 0.5 to 10 bar in half-bar increments, impact frequency from 1 to 21 Hz in single-hertz steps, and the shot count from 100 to 9,900 in hundreds. The unit draws 380 W, carries an 8-inch touch screen, measures 470 by 310 by 230 mm and weighs 15.5 kg, at either 220 V and 50 Hz or 110 V and 60 Hz. What the sheet omits is the pulse structure. No waveform, rise time, pulse duration or energy equivalent appears, and nothing describes cooling or a duty cycle for sessions of several thousand shots.

Those three ranges are wide enough to cover the protocols used in the published trials, which typically sit between 2.5 and 5 bar, 3 and 5 Hz, and 1,500 to 3,000 shots. That is a statement about range, not outcome, and the distinction matters here. NICE has reviewed extracorporeal shockwave therapy across tendon indications and reached the same conclusion each time: no major safety concerns, but evidence on efficacy is inconsistent and limited in quality and quantity.

This creates an obligation rather than a caveat. The guidance says the procedure should be used only with special arrangements for clinical governance, consent, and audit or research. In practice that means informing clinical governance leads, giving every patient clear written information about the uncertainty, and auditing and reviewing outcomes for everyone treated. Buying the device does not discharge any of it.

Medigear.uk lists the T501 for UK business buyers. Before ordering, request the class and declaration of conformity, the transmitter types supplied and their rated shot life, the duty cycle, and which voltage variant ships from the seller.

The T501 belongs in the settings that treat tendon and soft tissue problems conservatively: physiotherapy departments, podiatry clinics, sports injury practices, musculoskeletal services and the rehabilitation side of orthopaedics. The indications shockwave therapy is most often used for are Achilles tendinopathy, plantar fasciitis, tennis elbow and greater trochanteric pain syndrome, generally after conservative treatment has been tried and has not resolved the problem.

Where it sits in a pathway matters as much as what it does. Shockwave is a second-line option, offered when physiotherapy, activity modification, and pain relief have not worked, and the evidence base behind it is why the guidance attaches conditions. A service introducing it needs the governance conversation before the first list, not after it, because informing governance leads and setting up the audit are prerequisites rather than follow-up tasks.

Radial output shapes the clinical fit. Energy is highest at the skin and disperses with depth, which suits superficial tendon and muscle targets and behaves differently on deeper structures. Services planning to treat at depth should establish whether this modality reaches what they intend to treat before committing, since the sheet makes no claim either way.

Buying runs through the usual routes. NHS musculoskeletal services, private physiotherapy and podiatry groups, sports medicine practices, and veterinary users each apply their own procurement rules, and a Class IIa or IIb device must clear clinical governance as well as finance. Conformity documentation is issued by the manufacturer and provided by the seller. Report adverse incidents involving the device to the MHRA through the Yellow Card scheme.

Three output parameters, all with stated increments

Pressure, frequency and shot count are each given as a range with the step size attached: half a bar, one hertz, one hundred shots. Increments matter more than the endpoints on a device titrated to patient tolerance, because they determine how finely a clinician can work up during the first hundred shots of a session.

Ranges that encompass the published protocols

Trial work on tendon indications typically runs between 2.5 and 5 bar at 3 to 5 Hz, delivering 1,500 to 3,000 shots. All of that sits within the machine's published ranges, with room on either side, so a service following a protocol from the literature can reproduce it without pushing the equipment to its limits.

A shot counter built into the workflow

The count is set before the session rather than estimated during it, which makes the delivered dose a number rather than an impression. For a treatment where auditing outcomes is a stated requirement, having the delivered shots on the screen is the difference between an audit entry and a guess.

An eight-inch touch screen

A screen of that size takes a treatment protocol, a body map and the three live parameters without the operator hunting through menus mid-session. On a device where the free hand is holding an applicator against a patient, the number of interactions needed to change a setting is a practical matter.

A bench footprint one person can sit

At 470 by 310 by 230 mm and 15.5 kg, the head unit fits a standard treatment room bench or trolley and moves between rooms without a second pair of hands. That suits services running shockwave in whichever room is free rather than dedicating one to it.

Dual voltage across the range

Rated voltage covers both 220 V at 50 Hz and 110 V at 60 Hz. For groups operating across multiple regions, this widens where a unit can be redeployed, provided the supplied variant is confirmed at order.

Mains-powered with no consumable gas or fluid.

The device needs a socket and nothing else. No gel reservoir, no water buffer, no cylinder and no plumbed supply, which keeps room preparation to a bench and a power point.

The open questions are all answerable in writing.

Class, certificate, registration, UK Responsible Person, transmitter shot life, duty cycle, voltage variant. Every one exists in the manufacturer's file already, and none requires a trial or a site visit. How completely the answers come back says something useful about the supplier.

Radial pressure wave modality

The device generates pressure waves pneumatically, with output quoted in bar. Energy is highest at the skin surface and disperses with depth, distinguishing it from focused devices specified by energy flux density. The sheet itself uses neither term.

Output pressure 0.5 to 10 bar

Pressure is adjustable across the full range in 0.5-bar increments, giving twenty settings.

Impact frequency: 1 to 21 Hz

Frequency is adjustable in single-hertz steps across the full range, giving twenty-one settings.

Shot count 100 to 9,900

The number of impacts per session is set in increments of 100, giving ninety-nine settings, and is displayed rather than estimated.

380 W power draw

Input power is published at 380 W. No duty cycle, continuous-run limit or cooling arrangement is stated against it.

Eight-inch touch screen

Control is through an 8-inch touch screen. No resolution, preloaded protocol library, language options or patient record function is described.

Bench dimensions 470 × 310 × 230 mm

The head unit is published at those dimensions, with a net mass of 15.5 kg.

Packed dimensions 550 × 460 × 430 mm

The packed size and gross mass are also published, giving a shipping volume of roughly 0.109 cubic metres.

Dual rated voltage

Rated voltage is given as 220 V at 50 Hz or 110 V at 60 Hz. Whether a given unit is switchable or built to one standard is not stated.

Pulse structure not published.

No waveform, rise time, pulse duration, or energy equivalent in millijoules per square millimetre is provided, so the output cannot be mapped onto studies that report energy flux density.

Cooling and duty cycle not published.d

Nothing describes cooling, a continuous-operation limit or a rest interval between sessions for a 380 W device delivering several thousand impacts at a time.

Transmitter heads not specified.

The product photograph shows several applicators. The written specification names none, gives no diameters and does not say how many are supplied.

Handpiece and transmitter life not published.

No rated shot life appears for the handpiece, the projectile, or the transmitter faces, and no wear indication method is described, on a device whose counter runs to 9,900 per session.

Class, marking and registration not published.d

No device class, no marking under UKCA or CE, no Approved Body number, no MHRA registration and no UK Responsible Person appears anywhere on the sheet.

The T501 publishes its three output parameters properly, with the step size attached to each, and the ranges are wide enough to reproduce the protocols used in published tendon work. What it leaves out is the pulse structure, the duty cycle and the life of the parts that wear out, which, on a ballistic device, are the parts doing the work. The larger point sits outside the specification altogether. Shockwave therapy carries a standing expectation of clinical governance, written patient information about uncertain efficacy, and audit of every patient treated, and none of that arrives with the machine. Medigear.uk lists the T501 for UK business buyers and can arrange delivery, installation, commissioning, familiarisation and service cover. Request the class and declaration of conformity, transmitter shot life, duty cycle, and voltage variant from the seller with the quotation.

FAQ

Frequently Asked Questions

Everything buyers need to know about sourcing medical equipment through MediGear.

Radial, on the evidence of the specification itself. The output, quoted in bar, and the pneumatically driven handpiece put it squarely in the radial pressure-wave class, where a projectile strikes a transmitter and the wave spreads from the skin surface. Focused devices are specified in millijoules per square millimetre of energy flux density, generate their peak at a chosen depth, and use electromagnetic, electrohydraulic or piezoelectric generators. The two are not interchangeable. Radial energy is highest at the surface and disperses as it travels, so deep targets behave differently. The sheet uses neither term, so confirm the modality in writing and make sure the intended indications suit surface-weighted energy.

NICE says safety is not the concern; efficacy evidence is. Across tendon indications the finding has been consistent: extracorporeal shockwave therapy raises no major safety concerns, while current evidence on efficacy is inconsistent and limited in quality and quantity. Each conclusion is that the procedure should be used only with special arrangements for clinical governance, consent, and audit or research. Note also that the guidance has moved format. The Achilles tendinopathy guidance now sits as HealthTech guidance and replaces the earlier interventional procedures numbers, so a supplier quoting the old references is working from superseded material.

Three things, and all of them sit with the provider. Inform the organisation's clinical governance leads that the procedure is being introduced. Make sure every patient understands the uncertainty about efficacy and receives clear written information saying so, which is a consent question rather than a leaflet-tidying one. Then audit and review the outcomes of every patient treated, using a defined outcome measure. NICE publishes an outcomes audit tool for exactly this. None of that is optional, and none of it comes in the box.

Yes, comfortably, and that is worth checking rather than assuming. Trial protocols for tendon work commonly sit between 2.5 and 5 bar, at 3 to 5 Hz, delivering 1,500 to 3,000 shots per session. All three fall well inside the published ranges of 0.5 to 10 bar, 1 to 21 Hz and 100 to 9,900 shots. The half-bar and single-hertz increments are fine enough to titrate to patient tolerance during the first hundred shots, as most protocols are written. Range is not the same as suitability for a given indication, which stays a clinical decision.

Nothing published says, which is the gap that matters most on a device of this type. A ballistic handpiece works by firing a projectile against a transmitter thousands of times per session, and both the projectile and the transmitter faces are wear items with a finite shot life. The shot counter runs to 9,900 in a single session, so a busy list gets through them quickly. Ask for the rated shot life of the handpiece and of each transmitter, how wear is detected, which transmitters are supplied with the machine, and what the replacement interval looks like in sessions rather than years.

Not listed. The product photograph shows several applicators alongside the handpiece, and the written specification names none of them. Transmitter diameter and profile determine the treated area and how the energy spreads, so a machine supplied with one head does a narrower job than one supplied with a set. Ask for the transmitters included by name and diameter, which further heads are available, and whether they are interchangeable without tools.

Under UK MDR 2002, an active therapeutic device intended to administer energy falls under Rule 9, which puts it in Class IIa unless the energy is administered in a potentially hazardous way, in which case it is Class IIb. Either class requires a UK Approved Body, so a certificate with a number exists or the device is not lawfully on the market. The device must also be registered with the MHRA before being placed on the Great Britain market, and a manufacturer established outside the UK must appoint a UK Responsible Person whose details appear on the labelling or instructions. None of that is stated on the sheet. Ask for the class, the certificate and body number, the registration and the named UK Responsible Person.

The sheet lists 220 V at 50 Hz or 110 V at 60 Hz, but doesn't say which arrives. A 110 V unit is no use in a UK clinic without an intervening transformer, which brings its own electrical safety questions. Confirm the variant on the order, confirm the plug and lead supplied, and confirm whether the machine is dual-voltage switchable or built as one or the other. Ask at the same time for the electrical safety testing interval the manufacturer expects.

Not addressed anywhere. A pressure figure on a touch screen is a setting, not a measurement, and on a ballistic device the delivered energy falls as the projectile and transmitter wear. Without a calibration or verification routine there is no way to know whether 4 bar on the screen is still 4 bar at the skin after a year of lists. Ask what verification the manufacturer specifies, at what interval, who performs it, and whether any output measurement is possible on site.

Any service unwilling to put the governance, consent, and audit arrangements in place, because the guidance requires them rather than what a supplier suggests. Any clinic whose indications need energy delivered at depth, since radial output is weighted to the surface. Anyone who cannot obtain the class certificate and registration, since those aren't optional for a Class IIa or IIb device. And any buyer who needs the transmitter shot life before committing, which is a fair thing to insist on. For a physiotherapy or podiatry service already running an audit process and treating surface tendon problems, the published ranges cover the protocols in the literature.